[ET Net News Agency, 23 February 2026] SINO BIOPHARM (01177) rose 2.9% to HK$6.84.
It hits an intra-day high of HK$6.85, and an intra-day low of HK$6.66. The total shares traded was 6.37 million, with a value of HK$43.11m. The active buy/sell ratio is 77:23, with net buying turnover of HK$20.71m. UBS accounts for greatest net responsive buying turnover of HK$681,442, with volume weighted average price of HK$6.772. ABN AMRO CLEARING HK accounts for greatest net responsive selling turnover of HK$4.16m, with volume weighted average price of HK$6.762. The stock has risen a combined 4.9% over the past 3 consecutive trading days.
The Hang Seng Index now rose 635 points, or 2.4% to 27,048.
Basic Information| Nominal | 6.840 | % Chg | +2.86% |
| High | 6.850 | Low | 6.660 |
| Shares Tr | 6.37m | Turnover | 43.11m |
| 10-D SMA | 6.626 | %H.V | 34.750 |
| 20-D SMA | 6.597 | VWAP | 6.769 |
| 50-D SMA | 6.616 | RSI14 | 56.859 |
Status: Active buy/sell ratio is 77:23, with net buying turnover of HK$20.71m, rising a combined 4.9% over the past 3 consecutive trading days
Performance of stocks in the same sector or of relevance| Stock (Code) | Price (HK$) | Change (%) |
|---|
| SINO BIOPHARM (01177) | 6.84 | +2.86 |
| SIHUAN PHARM (00460) | 1.69 | Unchanged |
| GRAND PHARMA (00512) | 7.62 | +1.33 |
| HENGRUI PHARMA (01276) | 70.35 | +1.08 |
| LUYE PHARMA (02186) | 2.76 | +1.84 |
| FOSUN PHARMA (02196) | 20.54 | +2.19 |
| SH PHARMA (02607) | 11.94 | +1.79 |
| CHINARES PHARMA (03320) | 4.62 | +1.54 |
| HANSOH PHARMA (03692) | 37.34 | +1.63 |
| GOLDEN THROAT (06896) | 3.12 | -0.64 |
(ed)
